Last reviewed · How we verify

Silymarin — Competitive Intelligence Brief

Silymarin (Silymarin) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: silymarin. Area: Other.

marketed silymarin Urokinase-type plasminogen activator, Carbonic anhydrase 1, Carbonic anhydrase 12 Other Small molecule Live · refreshed every 30 min

Target snapshot

Silymarin (Silymarin) — F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Silymarin TARGET Silymarin F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica marketed silymarin Urokinase-type plasminogen activator, Carbonic anhydrase 1, Carbonic anhydrase 12

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (silymarin class)

  1. F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Silymarin — Competitive Intelligence Brief. https://druglandscape.com/ci/silymarin. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: